About N1X10
What would healthcare look like if the patient had more impact and control? N1X10, founded in 2019, is leading a paradigm shift to answer this question for cancer patients. We believe that by developing a global advocacy based network we can deliver the best treatment options for cancer patients.
About N1X10
What would healthcare look like if the patient had more impact and control? N1X10, founded in 2019, is leading a paradigm shift to answer this question for cancer patients. We believe that by developing a global advocacy based network we can deliver the best treatment options for cancer patients.
Led by a team of global experts in oncology research and care, and backed by leaders in the industry, N1X10 strives to improve health care and extend duration and quality of life for cancer patients.
New medical innovations are introduced on a daily basis, yet it takes years before they are widely adopted. Our proven track record with a broad range of cancer types, is demonstrating on a daily basis that it is possible for patients to get a different kind of care with greater value.
Led by a team of global experts in oncology research and care, and backed by leaders in the industry, N1X10 strives to improve health care and extend duration and quality of life for cancer patients.
New medical innovations are introduced on a daily basis, yet it takes years before they are widely adopted. Our proven track record with a broad range of cancer types, is demonstrating on a daily basis that it is possible for patients to get a different kind of care with greater value.
Our Mission
N1X10 is building the world’s first market network where cancer
patients can partner with oncology professionals to make the
best decisions that drive the best possible care.
Our Mission
N1X10 is building the world’s first
market network where cancer
patients can partner with
oncology professionals to make
the best decisions that drive the
best possible care.
Our Values
Management Team
Advocacy Team
Experts
Dr. Richard Kast
MD
Dr. Yoav Manaster
CEO of Progenetics
Andrew Hessel
Synthetic Biology
Alex Jadad
MD Dphil LLD
Advisors
Gil Somech
Partner at Naschitz, Brandes, Amir & Co.
Jim Eischen
Eischen Law Office / Lofty Learning
Kathy Poodiack, PA
Oncology Physician Assistant, Clinician and Researcher
Shalom Passy
S&T Tree Strategy
Yoram Tietz
Strategy – Hightech
Dana Porter
Founder, CMO
Board Member
Joel Cohen
Insurance
Jordan Shlain
Founder, Exec. Chair of Private Medical
Adding more years to your life
and more life to your years
Adding more years to
your life and more life to
your years
Get In Touch
We look forward to
hearing from you!
“*” indicates required fields